Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript - Thomson StreetEvents

Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript

Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript - Thomson StreetEvents
Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript
Published Oct 12, 2021
Published Oct 12, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of TERN.OQ presentation 12-Oct-21 6:30pm GMT

  
Report Type:

Transcript

Source:
Company:
Terns Pharmaceuticals Inc
Ticker
TERN.OQ
Time
6:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Thomas Yip - H.C. Wainwright & Co. - Analyst : Thank you very much, Dr. Quirk. Perhaps a couple of quick questions from me. First, with TERN-101, you mentioned there will be a Phase 2a combination study with TERN-501. Is the start of this study dependent on the part C drug-drug interaction study data or is it primarily based on the PK data readout around year-end 2021?


Question: Thomas Yip - H.C. Wainwright & Co. - Analyst : Understood. Thanks for clarifying. And then regarding the Phase 2a study, do you have any initial thoughts on what are some possible inclusion criteria? What are some notable efficacy endpoints that you see in the Phase 2a?


Question: Thomas Yip - H.C. Wainwright & Co. - Analyst : Sounds good. And then perhaps switching gears for TERN-201 for the AVIATION Phase 1b topline data early in 2022 and first quarter. And you touched on corrected T1. What are your expectations for cT1 results in this relatively small group of patients so far, and how do you expect cT1 to play a role in the future trials with TERN-201?


Question: Thomas Yip - H.C. Wainwright & Co. - Analyst : Either for NASH studies or specifically for TERN-201?


Question: Thomas Yip - H.C. Wainwright & Co. - Analyst : Thank you very much, Dr. Quirk, for the added insight, and also for your presentation today as well. Thank you for the rest of the Terns team for joining us today. And I also want to thank everyone in the audience for joining this presentation. Thank you very much, and have a good day.

Table Of Contents

Terns Pharmaceuticals Inc at JMP Securities Hematology Oncology Summit (Virtual) Transcript – 2022-12-06 – US$ 54.00 – Edited Transcript of TERN.OQ presentation 6-Dec-22 7:40pm GMT

Terns Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript – 2022-11-30 – US$ 54.00 – Edited Transcript of TERN.OQ presentation 30-Nov-22 8:55pm GMT

Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript – 2022-10-17 – US$ 54.00 – Edited Transcript of TERN.OQ presentation 17-Oct-22 3:30pm GMT

Terns Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript – 2022-09-14 – US$ 54.00 – Edited Transcript of TERN.OQ presentation 14-Sep-22 6:00pm GMT

Terns Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript – 2022-04-11 – US$ 54.00 – Edited Transcript of TERN.OQ presentation 11-Apr-22 6:15pm GMT

Terns Pharmaceuticals Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript – 2021-09-20 – US$ 54.00 – Edited Transcript of TERN.OQ presentation 20-Sep-21 6:55pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript" Oct 12, 2021. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Terns-Pharmaceuticals-Inc-at-H-C-Wainwright-NASH-Investor-Conference-Virtual-T15001677>
  
APA:
Thomson StreetEvents. (2021). Terns Pharmaceuticals Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript Oct 12, 2021. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Terns-Pharmaceuticals-Inc-at-H-C-Wainwright-NASH-Investor-Conference-Virtual-T15001677>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.